1. McCarty RC, Xian CJ, Gronthos S, Zannettino AC, Foster BK. Application of autologous bone marrow derived mesenchymal stem cells to an ovine model of growth plate cartilage injury. Open Orthop J 2010; 10(4):204–210.
2. Xian CJ, Zhou FH, McCarty RC. Intramembranous ossification mechanism for bone bridge formation at the growth plate cartilage injury site. J Orthop Res 2004; 22(2):417-426.
3. Ecklund K, Jaramillo D. Imaging of growth disturbance in children. Radiol Clin North 2001; 39(4):823-841.
4. Shaw N, Erickson C. Regenerative Medicine Approaches for the Treatment of Pediatric Physeal Injuries. Tissue Eng Part B Rev 2018; 24(2):85-97.
5. Bentley G, Greer RB. Homotransplantation of isolated epiphyseal and articular cartilage chondrocytes into joint surfaces of rabbits. Nature 1971; 230(5293):385-388.
6. Lee EH, Chen F, Chan J. Treatment of growth arrest by transfer of cultured chondrocytes into physeal defects. Journal of Pediatric Orthopedics 1998; 18(2):155-160.
7. Jin XB, Luo ZJ, Wang J. Treatment of rabbit growth plate injuries with an autologous tissue-engineered composite. An experimental study. Cells Tissues Organs 2006; 183(2):62–67.
8. Li WC, Xu RJ, Xue YL, Huang JX. Treatment of growth plate injury with microencapsulated chondrocytes. Biotechnology and Bioprocess Engineering 2013; 18(2):655–662.
9. Hansen AL, Foster BK, Gibson GJ, Binns GF. Growth-plate chondrocyte cultures for reimplantation into growth-plate defects in sheep. Characterization of cultures. Clinical Orthopaedics and Related Research 1990; 256(2):286–298.
10.Hui J, Ouyang H, Hutmacher D, Goh J, Lee E. Mesenchymal stem cells in musculoskeletal tissue engineering: a review of recent advances in National University of Singapore. Ann Acad Med Singapore 2005; 34(2):206-212.
11.Barry FP, Murphy JM. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol 2004; 36(4):568-584.
12.Caplan AI. Mesenchymal stem cells Journal of Orthopaedic Research. 1991; 9(5):641–650
13.Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997; 276(5309):71–74.
14.Dragoo JL , Samimi B, Zhu M. Tissue-engineered cartilage and bone using stem cells from human infrapatellar fat pads. Journal of Bone and Joint Surgery 2003; 85(5):740–747.
15.Awad HA, Wickham MQ, LeddyHA, Gimble JM. Chondrogenic difffferentiation of adipose-derived adult stem cells in agarose, alginate, and gelatin scaffffolds. Biomaterials 2004; 25(16):3211–3222.
16.Peterson B, Zhang J, Iglesias R. Healing of critically sized femoral defects, using genetically modifified mesenchymal stem cells from human adipose tissue. Tissue Engineering 2005; 11(12):120–129.
17.Jankowski RJ, Deasy BM, Huard J. Muscle-derived stem cells. Gene Therapy 2002; 9(10):642–647.
18.Deasy BM, Jankowski RJ, Huard J. Muscle-derived stem cells: characterization and potential for cell-mediated therapy. Blood Cells, Molecules, and Diseases 2001; 27(5):924–933.
19.Nakamura K, Shirai T, Morishita S, Uchida S, Saeki Miura. p38 mitogen-activated protein kinase functionally contributes to chondrogenesis induced by growth/differentiation factor-5 in ATDC5 cells Experimental Cell Research. 1999; 250(2):351–363.
20.Fukumoto T, Sperling JW, Sanyal. A Combined effects of insulin-like growth factor-1 and transforming growth factor-beta1 on periosteal mesenchymal cells during chondrogenesis in vitro. Osteoarthritis and Cartilage 2003; 11(1):55–64.
21.Driscoll SW, Fitzsimmons JS. The role of periosteum in cartilage repair. Clinical Orthopaedics and Related Research 2001; 13(2):190–207.
22.Barry FP, Murphy JM. Mesenchymal stem cells: clinical applications and biological characterization. International Journal of Biochemistry and Cell Biology 2004; 36(4):568–584.
23.Bari CD, Accio DF, Vermeesch JR, Raymackers JM, Luyten FP. Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. Journal of Cell Biology 2003; 160(6):909–918.
24.Tylzanowski P, Luyten FP. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis and Rheumatism 2001; 44(8):1928–1942.
25.Li WC, Xu RJ, Huang JX, Bao X, Zhao B. Treatment of rabbit growth plate injuries with oriented ECM scaffold and autologous BMSCs.Sci Rep 2017; 7(7):440–451.
26.Chen F, Hui HP, Chan WK, Lee EH. Cultured Mesenchymal Stem Cell Transfers in the Treatment of Partial Growth Arrest. J Pediatr Orthop 2003; 23(4):425-429.
27.Li L, Hui HP, Goh CH, Fen Chen F, Lee EH. Chitin as a Scaffold for Mesenchymal Stem Cells Transfers in the Treatment of Partial Growth Arrest. J Pediatr Orthop 2004; 24(2):205-210
28.PLÁNKA L, NEÁS A,GÁL P, KECOVÁ H, FILOVÁ E. Prevention of Bone Bridge Formation Using Transplantation of the Autogenous Mesenchymal Stem Cells to Physeal Defects: An Experimental Study in Rabbits. ACTA VET 2007; 76(2):253–263.
29.Planka L, Gal P, Kecova H, Klima J, Hlucilova J. Allogeneic and autogenous transplantations of MSCs in treatment of the physeal bone bridge in rabbits. BMC Biotechnol 2008; 12(8):70–79.
30.Plánka L, Necas A,Srnec R, Rauser P, Starý D, Jančář J. Use of Allogenic Stem Cells for the Prevention of Bone Bridge Formation in Miniature Pigs. Physiol Res 2009; 58(6):885-893
31.McCarty RC, Xian CJ, Gronthos S, Bruce KF. Application of Autologous Bone Marrow Derived Mesenchymal Stem Cells to an Ovine Model of Growth Plate Cartilage Injury. Open Orthop J 2010; 23(4):204-210.
32.Yoshida K, Higuchi C, Nakura A, Nakamura N. Treatment of Partial Growth Arrest Using an In Vitro-generated Scaffold-free Tissue engineered Construct Derived From Rabbit Synovial Mesenchymal Stem Cells. J Pediatr Orthop 2012; 32(3):314-321.
33.Azarpira MR, Shahcheraghi GH, Ayatollahi M, Geramizadeh B. Tissue engineering strategy using mesenchymal stem cell-based chitosan scafolds in growth plate surgery: A preliminary study in rabbits. Orthop Traumatol Surg Res 2015; 101(5):601-605.
34.Moher D, Liberati A, Tetzlaff J, Altman DG. Reprint preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Phys Ther 2009; 89(9):873-880.
35.Jones IE, Williams SM, Dow N. How many children remain fracture-free during growth? A longitudinal study of children and adolescents participating in the dunedin multidisciplinary health and development study. Osteoporosis International 2002; 13(12):990–995.
36. Mizuta T, Benson WM, Foster BK, Paterson DC. Statistical analysis of the incidence of physeal injuries. Journal of Pediatric Orthopaedics 1987; 7(5):518–523.
37. Ogden JA. Growth slowdown and arrest lines. Journal of Pediatric Orthopaedics 1984; 4(4): 518–523
38. Wattenbarger JM, Gruber HE, Phieffffer LS. Physeal fractures, part I: histologic features of bone, cartilage, and bar formation in a small animal model. Journal of Pediatric Orthopaedics 2002; 22(6):703–709.
39. Chung R, Foster BK, Xian CJ. Preclinical studies on mesenchymal stem cell-based therapy for growth plate cartilage injury repair. Stem Cells Int 2011; 5(7):125–135.
40. Xian CJ, Foster BK, et al. Repair of injured articular and growth plate cartilage using mesenchymal stem cells and chondrogenic gene therapy. Stem Cell Res Ther 2006; 1(2):213-229
41. Leo AJ, Grande DA, et al. Mesenchymal stem cells in tissue engineering. Cells Tissues Organs 2006; 183(3):112-122.
42. Kaviani M, Azarpira N, Aghdaie MH, Esfandiari E, Geramizadeh B, Nikeghbalian S. Comparison of human mesenchymal stem cells derived from various compartments of human adipose tissue and tunica adventitia layer of the arteries subsequent to organ donation. Int J Organ Transplant Med 2019; 10(2):65-73.